| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2025 | Oct 22, 2025 | Roivant Sciences Ltd. | Director | Sell | 67.5 | +631 | 0.58% | ✗ | $2.8K |
| Sep 10, 2025 | Sep 12, 2025 | Roivant Sciences Ltd. | Director | Sell | 91.3 | +11,242 | 11.63% | ✗ | $45.2K |
| Jul 17, 2025 | Jul 21, 2025 | Roivant Sciences Ltd. | Director | Sell | 77.5 | +960 | 1.00% | ✗ | $2.8K |
| Apr 17, 2025 | Apr 21, 2025 | Roivant Sciences Ltd. | Director | Sell | 77.5 | +1,103 | 1.17% | ✗ | $2.8K |
| Jan 23, 2025 | Jan 27, 2025 | Roivant Sciences Ltd. | Director | Sell | 77.5 | +942 | 1.01% | ✗ | $3.4K |
| Sep 12, 2024 | Sep 16, 2024 | Roivant Sciences Ltd. | Director | Sell | 46.3 | -3,056 | -3.20% | ✗ | $37K |
| Apr 24, 2024 | Apr 26, 2024 | Roivant Sciences Ltd. | Director | Sell | 77.5 | +1,197 | 1.57% | ✗ | $3.2K |
| Oct 16, 2022 | Oct 18, 2023 | Roivant Sciences Ltd. | Director | Sell | 77.5 | +907 | 1.23% | ✓ | $7.1K |
| Sep 18, 2023 | Sep 20, 2023 | Roivant Sciences Ltd. | Director | Sell | 28.8 | -6,752 | -8.38% | ✓ | $75.4K |
| Dec 29, 2021 | Jan 3, 2022 | BridgeBio Pharma, Inc. | Director | Buy | 100.0 | +80,000 | 942.17% | ✗ | $1.2M |